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Different effects of angiotensin II and catecholamine on renal dent cells and leukocytes within the inflammatory region.
cell apoptosis and proliferation in rats. Apoptosis may also underlie the pathology of a variety
Background. We have recently found that chronic infusion of renal diseases, such as ischemia/reperfusion injury [1],of angiotensin II (Ang II) into rats resulted in an impairment
glomerulonephritis [2], and obstructive uropathy [3]. Itof renal function, whereas norepinephrine (NE) infusion did
is postulated that an imbalance between proliferationnot. We investigated whether chronic infusion of Ang II and
NE caused different degrees of renal cell apoptosis and prolif- and apoptosis plays a role in renal damage, which would
eration. be histologically manifested by renal cellular hypertro-
Methods. Rats were made hypertensive via continuous infu- phy [4] or atrophy [5, 6].sion of either Ang II or NE for up to seven days. Renal cell
There are several proximal mediators that initiate theapoptosis and proliferation were analyzed by the terminal
cascade of apoptosis in response to various renal insults.deoxynucleotidyl transferase-mediated dUTP-biotin nick end
labeling (TUNEL) technique and staining with antibody against These include inflammatory cytokines [7], the lipid-signal-
proliferating cell nuclear antigen (PCNA), respectively. In ing molecule ceramide [8], and various types of reactive
some experiments, an inducer or inhibitor of heme oxygenase-1 oxygen species [9].(HO-1) was administered to investigate the possible role of HO-1
The finding that angiotensin II subtype 1 (AT1) recep-in renal cell homeostasis.
tor blockade resulted in a decrease in apoptosis in theResults. Infusion of Ang II, but not NE, resulted in approxi-
mately a sevenfold increase in bax protein at seven days of kidneys of rats receiving cyclosporine suggests that acti-
infusion. The TUNEL assay revealed that Ang II infusion sig- vation of the renin-angiotensin system (RAS) may also
nificantly increased the number of apoptotic cells, whereas NE contribute to the development of apoptosis [10] as wellinfusion did not. TUNEL- and PCNA-positive cells were mainly
as cell proliferation [11]. In the heart, an active role of theseen in the tubulointerstitial region of Ang II-infused rats. Ang II
RAS in apoptosis has been demonstrated more directly byinduced increased positivity of TUNEL, and PCNA was blocked
completely by losartan, but only partially by hydralazine. Induc- the finding that angiotensin II (Ang II) administration
tion of HO-1 reduced and inhibition of HO increased Ang II- induces apoptosis [12]. On the other hand, the findings
induced cell proliferation. that apoptosis is increased in the target organs of geneti-Conclusions. These data suggest that Ang II plays a pivotal
cally hypertensive animals [13, 14] and in vein graftsrole in the development of renal cell proliferation and apoptosis
exposed to biomechanical stress [15] suggest that me-in the setting of hypertension. The renal HO system may modu-
late proliferative and pro-apoptotic effects of Ang II. chanical or hemodynamic stress have a role in apoptosis.
We have recently reported that Ang II infusion for
seven days decreased glomerular filtration ratio and in-
Apoptosis exerts a beneficial effect by regulating the creased urinary protein excretion, whereas norepineph-
number of renal cells through deleting both excess resi- rine (NE) infusion did not, irrespective of its comparable
hypertensive effect [16]. The purpose of the present
study was to investigate whether cell apoptosis and pro-
1 Drs. Aizawa and Ishizaka contributed equally to this study. liferation would be induced in the kidneys of rats made
hypertensive by chronic administration of either Ang IIKey words: oxidative stress, blood pressure, heme oxygenase-1, cellular
hypertrophy, cell death, interstitial cell apoptosis, hydralazine. or NE in order to assess whether renal functional impair-
ment and renal cell apoptosis/proliferation were seen inReceived for publication April 25, 2000
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lated in the kidneys of rats with administration of Ang II, used for detection. Bands were visualized and quanti-
tated using lumino-analyzer (LAS-1000; Fuji Photo Film,but not NE [16]. Since HO-1 may have anti-apoptotic
[17] as well as antiproliferative properties [18], we also Tokyo, Japan).
investigated the possible role of HO system in the regula-
Immunohistochemistrytion of renal cell proliferation and apoptosis in hyperten-
sive rats. Immunohistochemistry was performed following the
protocol described previously [20]. Briefly, deparaffin-
ized sections were preincubated with 10% horse serum.
METHODS
Sections were then incubated with the antibodies against
All of the protocols used in the present study were bax (Santa Cruz), HO-1 (StressGen, Victoria, BC, Can-
approved by the Animal Research Committee of the ada), or proliferating cell nuclear antigen (PCNA; Dako,
University of Tokyo (Tokyo, Japan). Carpinteria, CA, USA) at a 1:200 dilution at 378C for one
hour. Slides were then washed with phosphate-buffered
Animal models
saline (PBS) three times and incubated with biotinylated
The rat hypertension model was created in male secondary antibody at a 1:1000 dilution. After treating
Sprague-Dawley rats (Nippon Bio-Supply Center, Tokyo, the slides with the Elite ABC kit (Vector Laboratories,
Japan) by subcutaneous implantation of an osmotic mini- Burlingame, CA, USA), antigens were visualized using
pump (Alzet model 2001; Alza, Palo Alto, CA, USA) as the 3,3-diaminobenzidine tetrahydrochloride (Dako) sys-
described previously [19]. Val5-Ang II (Sigma, St. Louis, tem. Counterstaining was performed with methyl green
MO, USA) was infused at a rate of 0.7 mg/kg/day, and (Dako). The number of PCNA-positive cells in each
NE was infused at a rate of 2.8 mg/kg/day for up to specimen was calculated in a blinded fashion by counting
seven days [19]. Systolic blood pressure was measured the number of PCNA-positive cells in 20 nonoverlapping
in conscious rats (N 5 9) by tail-cuff plethysmography fields viewed at 3250 magnification and expressed as
(UR-5000; Ueda Seisakusyo, Tokyo, Japan). In some the mean number 6 SEM per high-power field (hpf).
experiments, the selective AT1 receptor antagonist losar-
Determination of apoptosistan (25 mg/kg/day; a kind gift from Dr. R.D. Smith,
Dupont/Merck, Boston, MA, USA) or the nonspecific Paraffin-embedded sections (5 mm in thickness) from
vasodilator hydralazine (15 mg/kg/day; Sigma) was given rat kidneys were examined via the terminal deoxynucleo-
in the drinking water, beginning two days before pump tidyl transferase (TdT)-mediated dUTP-biotin nick end
implantation and continued until the time of sacrifice as labeling (TUNEL) technique using an Apoptosis Detec-
described previously. All rats were fed a standard chow tion Kit (Wako Chemicals, Osaka, Japan) as described
for rats, MF (Oriental Yeast, Tokyo, Japan). The amount previously [21], except with minor modifications. Briefly,
of drinking water did not apparently differ among the sections were treated with 20 mg/mL of proteinase K
rats with various treatments. in PBS (sodium phosphate 50 and sodium chloride 200
Some rats were subjected to daily intraperitoneal in- mmol/L, pH 7.4) for 10 minutes and incubated at 378C
jections of the HO-1 inducer hemin (50 mmol/kg/day; for 30 minutes in TdT enzyme. The sections were then
Sigma) or HO-1 inhibitor zinc-protoporphyrin (ZnPP; immersed in 3% hydrogen peroxide in methanol for five
50 mmol/kg/day; Porphyrin Products, Logan, UT, USA), minutes. After a brief wash in PBS (3 times), slides were
which was started two days before pump implantation treated with antidigoxigenin antibodies tagged with
and continued until sacrifice as described previously [16]. horseradish peroxidase for 10 minutes. Visualization of
labeled, incorporated nucleotides was carried out with
Protein purification and Western blot analysis diaminobenzidine (Dako). Slides were then counter-
Protein was isolated by homogenization of the samples stained with 1% methyl green. The number of TUNEL-
within the lysis buffer [50 mmol/L HEPES, 5 mmol/L ethyl- positive cells in each specimen was calculated in a
enediaminetetraacetic acid (EDTA), and 50 mmol/L NaCl, blinded fashion by counting the number of PCNA-posi-
pH 7.5) containing protease inhibitors [10 mg/mL aproti- tive cells in 20 nonoverlapping fields viewed at 3250
nin, 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), magnification and expressed as the mean number 6 SEM
and 10 mg/mL leupeptin], and Western blot analysis was per hpf.
performed as described previously [19]. Antibodies against
DNA ladder assaybax (Santa Cruz, Santa Cruz, CA, USA) and bcl-2 (Trans-
duction Laboratory) were used at a 1:1000 dilution, and Tissue samples were homogenized in a buffer [10
horseradish-conjugated secondary antibody (Jackson Im- mmol/L Tris, pH 8.0, 100 mmol/L NaCl, 25 mmol/L
munoresearch, West Grove, PA, USA) was used at a EDTA, 0.5% sodium dodecyl sulfate (SDS), and 1.0
1:2000 dilution. The ECL Western blotting system (Am- mg/mL proteinase K] and incubated at 378C overnight.
Samples were then treated with RNase A (Sigma) forersham Life Sciences, Arlington Heights, IL, USA) was
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Fig. 1. Effect of continuous infusion of angio-
tensin II (Ang II) on blood pressure and ex-
pression of apoptosis-related proteins. (A)
Time course of systolic blood pressure in
Ang II-infused rats (N 5 9). Ang II was contin-
uously infused at a rate of 0.7 mg/kg/day for
the indicated number of days. (B, C, E, and
F) Effects of angiotensin II (Ang II) on apo-
ptosis-related protein expression. After Ang II
was infused for specified time periods, the kid-
neys were harvested, and the expression of
bax (B and E) and bcl-2 (C and F) was exam-
ined. (B and C) Data from five to seven ani-
mals are summarized in the bar graphs. (D
and E) Representative immunoblots. (F) Coo-
massie brilliant blue stained sodium dodecyl
sulfate-polyacrylamide gels of protein samples
from the kidneys of rats that had received
continuous angiotensin II infusions for the in-
dicated number of days. The same samples
were used for the representative pictures of
immunoblot analysis of bax and bcl-2 expres-
sion and Coomassie brilliant blue staining.
*P , 0.05 and †P , 0.01 vs. controls, respec-
tively.
two hours at 378C, and genomic DNA was precipitated RESULTS
with ethanol. Equal amounts of DNA samples were Effect of angiotensin II on blood pressure and
loaded onto a 1% agarose gel, and the gel was stained apoptosis-related proteins
with ethidium bromide. Infusion of Ang II effectively increased blood pressure
(Fig. 1A). At first, we examined whether infusion of Ang II
Statistical analysis changed expression of pro-apoptotic (bax) and anti-apo-
Data are expressed as means 6 SEM. Analysis of ptotic (bcl-2) proteins. An immunoblot showed that bax
variance (ANOVA) followed by a multiple comparison protein expression was markedly up-regulated in the kid-
test was used for comparisons of the initial data before neys of Ang II-induced hypertensive rats (Fig. 1 B, D).
expression as a percentage of the control using the statis- In contrast, the expression of bcl-2 protein remained
tical analysis software Statistica version 5.1 J for Win- unchanged after Ang II infusion (Fig. 1 C, E). Even
dows (StatSoft Inc., Tulsa, OK, USA). A value of P , loading of the protein sample in each lane was confirmed
by the Coomassie staining (Fig. 1F).0.05 was considered statistically significant.
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Fig. 2. Localization of bax and heme oxygen-
ase-1 (HO-1). (A) Hematoxylin-eosin staining
of the kidneys of Ang II-induced hypertensive
rats. (B–I) Bax and HO-1 staining were per-
formed on serially sectioned specimens. Bax
(B and C) and HO-1 (D and E) staining in
the kidney of Ang II-induced hypertensive rats.
The majority of the bax-positive cells were
also positive for HO-1 with some discrepan-
cies (arrows in D and asterisks in E). Bax (F
and G) and HO-1 (H and I) staining in the
kidneys of normotensive rats.
Fig. 4. Representative photographs of TUNEL-
positive cells in the kidney of rats receiving
either angiotensin II (Ang II) or norepineph-
rine (NE). (A–F) TUNEL staining. (A and D)
Kidney specimen of the control rat. (B and E)
Kidney specimen of the rat infused Ang II
for seven days. Several TUNEL-positive nuclei
were observed (arrows in B). Higher magnifi-
cation showed that positive TUNEL staining
was seen in both tubular (arrow in E) and
interstitial (arrowhead in E) regions. (C and
F) Kidney specimen of the rat infused NE for
seven days. (G–L) PCNA immunohistochem-
istry. (G and J) Kidney specimen of the control
rat. (H and K) Kidney specimen of the rat
infused Ang II for three days. Several PCNA-
positive nuclei were observed. (I and L) Kid-
ney specimen of the rat infused NE for three
days. D, E, F, J, K, and L are magnified views
of bracketed regions in A, B, C, G, H, and I,
respectively. Original magnifications are 3250
(A–C and G–I) and 3800 (D–F and J–L).
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Immunohistochemistry of bax protein
Immunohistochemistry demonstrated that bax protein
was present in both the proximal and distal tubular epi-
thelial cells (Fig. 2B), but not in the glomeruli (Fig. 2C)
in the kidneys of Ang II-induced hypertensive rats. We
previously found that intense HO-1 staining is present
in the tubular epithelial cells in the kidney of Ang II-
induced hypertensive rats. Staining of the continuous
section revealed that many tubular epithelial cells posi-
tive for bax staining were also positive for HO-1 staining
(Fig. 2 D, E), although overlapping was not complete
(arrows and asterisks in Fig. 2 D, E, respectively). In the
kidney of normotensive rats, bax staining was barely
detectable in the tubular epithelial cells (Fig. 2 F, G). In
contrast, distinct HO-1 staining was detectable along the
basal side of tubular epithelial cells (Fig. 2 H, I), as
described previously [16].
Effects of antihypertensive drugs and norepinephrine
on blood pressure and apoptosis-related proteins
Next, we investigated whether Ang II-induced up-reg-
ulation of bax protein was a pressor-dependent or pres-
sor-independent event. For this purpose, either the spe-
cific AT1 receptor antagonist losartan or the nonspecific
vasodilator hydralazine was orally administered to rats
receiving continuous Ang II infusions. Rats were sacri-
ficed at seven days of infusion of either Ang II or NE.
Both losartan and hydralazine effectively normalized the
blood pressure of Ang II-infused rats (126 6 5 and 133 6
8 mm Hg, P 5 NS compared with controls, respectively).
Ang II-induced up-regulation of bax protein was blocked
completely by losartan, but only partially by hydralazine
(Fig. 3A), suggesting that chronic Ang II infusion in-
creased renal bax protein levels via an AT1 receptor-
mediated manner, and only partially via a pressor-depen-
dent manner. Continuous Ang II infusion at a dose of
0.25 mg/kg/day for seven days, which did not significantly
Fig. 3. Effects of antihypertensive drugs, subpressor doses of angioten-increased blood pressure (137 6 3 mm Hg, P 5 NS
sin II (Ang II) and norepinephrine (NE) on apoptosis-related proteincompared with control), did not change renal bax expres- expression. (A, left) Effects of losartan (Los) and hydralazine (Hyd).
sion. Interestingly, NE infusion for seven days, irrespec- Losartan completely blocked Ang II-induced bax up-regulation, while
hydralazine only partially blocked such an up-regulation. (Right) Effectstive of its comparable hypertensive effect on Ang II
of NE and a subpressor dose of Ang II (0.25 mg/kg/day). NE infusion(196 6 6 mm Hg, P , 0.01 and P 5 NS compared with did not increase renal bax expression. (B) Effect of vasopressors and
the control and Ang II group, respectively), did not up- vasodilators on bcl-2 expression in the kidney. Expression of bcl-2 in
each group displays a relatively large variation, and neither vasopressorsregulate bax protein. Neither Ang II (0.7 or 0.25 mg/kg/
nor vasodilators significantly alter the bcl-2 expression within the kid-
day), losartan, hydralazine, nor NE significantly changed ney. (A and B, upper panels) Representative immunoblots. (A and B,
lower panels) Data from four to six animals are summarized in a barbcl-2 protein levels (Fig. 3B).
graph. *P , 0.01 vs. sham-operated controls; †P , 0.05 vs. Ang II-
infused rats.Determination of apoptosis by TUNEL assay
Next, the number of apoptotic cells in the kidney was
quantitated using TUNEL technique. In addition to
brown staining, apoptotic nuclei were identified by con- significantly increased after three days of Ang II (0.7
densed nuclear material and vacuolization of the cyto- mg/kg/day) infusion (P , 0.01 compared with control)
and further increased after seven days of Ang II infusionplasm (Fig. 4 B, E). Within the both tubular and intersti-
tial regions, the number of TUNEL-positive cells was (P , 0.01 compared with control and day 3; Table 1).
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Table 2. Effect of angiotensin II and norepinephrine infusion onTable 1. Effect of angiotensin II and norepinephrine infusion on
tubular and interstitial cell apoptosis tubular and interstitial cell proliferation
Tubular region Interstitial regionTubular region Interstitial region
GroupGroup 0.660.1 1.460.3 1.160.2 1.460.4
ControlControl
Treatment day 3 day 7 day 3 day 7 Treatment day 3 day 7 day 3 day 7
Ang II 0.7 mg/kg/day 13.162.4b 5.661.8b 16.062.7b 5.560.6bAng II 0.7 mg/kg/day 2.760.9a 5.161.8b 3.961.6b 6.262.0b
NE 0.560.3c 0.460.1c 1.460.7c 1.660.1d NE 1.160.3d 1.260.4c 1.260.2d 2.360.5a,d
Hydralazine ND 0.860.3d ND 1.060.2dHydralazine ND 0.460.1c ND 1.060.3d
Hydralazine1Ang II 1.360.3a,c 2.860.5b,c 2.260.9 4.160.6b,c Hydralazine1Ang II 12.863.4b 4.760.9b 13.262.6b 8.161.0b
Losartan ND 1.260.2d ND 1.360.4dLosartan ND 0.360.1d ND 1.460.5d
Losartan1Ang II ND 0.460.1d ND 1.360.8d Losartan1Ang II ND 1.260.0d ND 1.760.5c
Low Ang II ND 1.060.1d ND 1.460.2dLow Ang II ND 0.360.2d ND 1.860.1d
Angiotensin II (Ang II) or norepinephrine (NE) was continuously infusedAngiotensin II (Ang II) or norepinephrine (NE) was continuously infused
for 7 consecutive days. The number of TUNEL-positive cells in each specimen for 7 consecutive days. The number of PCNA-positive cells in each specimen
was calculated by counting the number of PCNA-positive cells in 20 nonoverlap-was calculated by counting the number of TUNEL-positive cells in 20 nonover-
lapping fields viewed at 3250 magnification. Data from 6 to 8 rats are summarized ping fields viewed at 3250 magnification. Data from 6 to 8 rats are summarized
and expressed as the mean number 6 SEM per high power field. ND indicatesand expressed as the mean number 6 SEM per high power field. ND indicates
not done. not done.
a P , 0.05 and b P , 0.01 compared with the controla P , 0.05 and b P , 0.01 compared with the control
c P , 0.05 and d P , 0.01 compared with Ang II (0.7 mg/kg/day)-infused rats c P , 0.05 and d P , 0.01 compared with Ang II (0.7 mg/kg/day)-infused rats
control rats or rats receiving NE or subpressor doses ofIn contrast, chronic infusion of NE did not increase the
Ang II (Fig. 5B), which were consistent with the findingnumber of TUNEL-positive cells at either time point.
of TUNEL staining.Losartan completely, but hydralazine only partially,
blocked the Ang II-induced increase in TUNEL-positive
Effects of inducer and inhibitor of HO on renalcells in the tubulointerstitial region.
cell apoptosis
Immunohistochemical analysis of renal In a previous article, we demonstrated that administra-
cell proliferation tion of hemin, an HO inducer, ameliorated and the ad-
ministration of ZnPP, an HO inhibitor, exacerbated anWe also quantitated the number of proliferating cells
Ang II-induced decrease in glomerular filtration ratein the kidney by immunohistochemical analysis (Fig. 4
and an increase in proteinuria [16]. Therefore, we nextH, K). After either three or seven days of infusion, Ang II
investigated the effects of hemin and ZnPP on Ang II-increased the number of PCNA-positive cells (P , 0.01
induced increase in cell apoptosis and proliferation.compared with control), and the number of PCNA-posi-
TUNEL staining demonstrated that ZnPP administra-tive cells was significantly greater at day 3 than at day 7
tion did not significantly changed Ang II-induced increaseof Ang II infusion (P , 0.01; Table 2). NE infusion did
in TUNEL-positive cells in tubulointerstitial region. Innot result in enhanced PCNA staining after three days of
contrast, hemin administration significantly suppressedinfusion in tubulointerstitial region. NE infusion slightly,
Ang II-induced increase in TUNEL-positive cells at ei-but significantly, increased the number of PCNA-positive
ther three or seven days of Ang II infusion (Table 3).cells after seven days of infusion in the interstitial region
The number of TUNEL-positive cells in the kidney of(Table 2), although the extent of such staining was signifi-
rats receiving both Ang II and hemin was also signifi-cantly less than that seen in Ang II-infused rats (P ,
0.01). Again, losartan completely, but hydralazine only cantly smaller than that in the kidney of rats receiving
both Ang II and hydralazine at day 7 of Ang II infusion,partially, blocked Ang II-induced increase in PCNA-posi-
tive cells in tubulointerstitial region. In the glomerular suggesting that a factor(s) other than antihypertensive
properties may mediate the anti-apoptotic effect of hemin.region, none of the treatments significantly increased the
number of TUNEL- or PCNA-positive cells compared
Effects of inducer and inhibitor of HO on renalwith the control animals (data not shown).
cell proliferation
Detection of chromosomal DNA fragmentation Immunohistochemistry demonstrated that ZnPP ad-
ministration significantly increased PCNA-positive cellsAs illustrated (Fig. 5), chromosomal DNA from the
kidneys of Ang II-induced hypertensive rats showed a at both three and seven days (tubular region) and at day 7
(interstitial region) of Ang II infusion. In contrast, hemintypical DNA electrophoretic pattern on an agarose gel.
DNA fragmentation was completely blocked by losartan, administration significantly decreased Ang II-induced
increase in PCNA-positive cells at three days of Ang IIbut not by hydralazine (Fig. 5A). No DNA fragmenta-
tion could be detected in the kidneys obtained from infusion (Table 4).
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Table 3. Effect of hemin and zinc protoporphyrin on angiotensin II-
induced tubular and interstitial cell apoptosis
Tubular region Interstitial region
Group 0.660.1 1.460.3
Control
Treatment day 3 day 7 day 3 day 7
Ang II 0.7 mg/kg/day 2.760.9a,e 5.161.8b,e 3.961.6a 6.262.0b,e
Hydralazine1Ang II 1.360.3a,c 2.860.5b,c 2.260.9 4.160.6b,c
Hemin ND 0.460.1d,f ND 1.060.2d,f
Hemin1Ang II 1.360.2a,c 1.360.2a,d,f 1.860.3d 1.660.2d,e
ZnPP ND 1.060.2d,e ND 1.160.2d,f
ZnPP1Ang II 2.060.1a 6.761.0b,f 2.960.2a 7.160.6b,f
Angiotensin II (Ang II) was continuously infused for 7 consecutive days. The
number of TUNEL-positive cells in each specimen was calculated by counting
the number of TUNEL-positive cells in 20 nonoverlapping fields viewed at 3250
Fig. 5. Ang II-induced DNA fragmentation of the kidneys of rats re- magnification. Data from 6 to 8 rats are summarized in the table and expressed
ceiving vasopressors and/or vasodilators. Genomic DNA samples puri- as the mean number 6 SEM per high power field. ND indicates not done.
a P , 0.05 and b P , 0.01 compared with the controlfied from the kidney of rats receiving the indicated drug(s) were loaded
c P , 0.05 and d P , 0.01 compared with Ang II (0.7 mg/kg/day)-infused ratsonto 1.5% agarose gel. (A) Rats were continuously infused pressor
e P , 0.05 and f P , 0.01 compared with hydralazine 1 Ang II groupdoses (0.7 mg/kg/day) of Ang II for seven days with or without receiving
vasodilators. Losartan completely inhibited the “ladder” formation in-
duced by continuous Ang II infusion. (B) Subpressor doses (0.25 mg/
kg/day) of Ang II or NE did not result in DNA ladder formation.
opment of renal cell apoptosis. Whether Ang II and NE
actually have different potentials in inducing reactive
oxygen species in the kidney of hypertensive animals, asDISCUSSION
has been shown in the rat aortas [26], should be studiedIn the present study, we demonstrated that chronic
further in the future. Second, it should be kept in mindinfusion of Ang II at a pressor dose increased renal cell
that increases in the number of PCNA-positive cells inapoptosis in the rat kidney. This Ang II-induced cell
the tubulointerstitial region preceded increases in apo-apoptosis was blocked completely by losartan, but only
ptosis in the tubulointerstitial region in Ang II-infusedpartially by hydralazine. In contrast, NE infusion, irre-
rats. Therefore, increased apoptosis may be, at least par-spective of its comparable hypertensive effect, did not
tially, a compensatory mechanism in response to cellularresult in enhanced apoptosis, suggesting that Ang II plays
proliferation. Different effect of Ang II and NE in renala pivotal role in renal cell apoptosis in the setting of
cell proliferation may be explained by proteinuric effecthypertension.
of Ang II, since the mitogenic pathway in tubular epithe-Different effects on renal cell apoptosis resulting from
lial cells is activated in proteinuric states [27]. However,Ang II and NE administration may be explained in three
the finding that hydralazine treatment did not decreaseways. First, in the previous set of experiments, we found
the Ang II-induced enhanced cell proliferation indicatesthat continuous infusion of Ang II, but not NE, increased
that increased proteinuria was not solely responsible forproteinuria [16]. Since proteinuria induces tubular cell
the Ang II-induced increases in PCNA positivity. Ang IIapoptosis in rats [22], different apoptotic effects between
may have enhanced renal cell proliferation via the directAng II and NE may be derived from their different
action of Ang II [28] or Ang II-induced increase in super-effects with regard to increasing proteinuria. On the
oxide production [23]. It has been reported that a major-other hand, we previously showed that hydralazine treat-
ity of apoptotic cells are actually within the phagolyso-ment completely normalized Ang II-induced increase in
somes of adjacent cells or infiltrating macrophages [29];proteinuria [16]. Since hydralazine only partially sup-
therefore, it is difficult to assess whether apoptosis out-pressed Ang II-induced renal cell apoptosis in the pres-
weighed proliferation. However, since Ang II infusionent study, a factor(s) other than proteinuria, such as
may cause tubular atrophy as well as cell proliferationincreased superoxide [23], may play a role in renal cell
[11], an imbalance between cell proliferation and apopto-apoptosis in the kidney of Ang II-infused rat. We found
sis may play a role in Ang II-induced renal damage.that some of the tubular epithelial cells express high
Third, it is possible that Ang II-induced microvascularlevels of both HO-1 and bax in Ang II-induced hyperten-
injury with peritubular capillary loss [30] resulted in ansive rats. HO-1 is known to be induced by various reac-
enhanced apoptosis that eventually will lead to tubuloin-tive oxygen species [24, 25] and therefore represents a
terstitial injury.reliable marker of oxidative stress. The findings that
We also found that induction of HO-1 decreased andAng II administration causes increases in HO-1 and bax
inhibition of HO increased the incidence of tubulointer-expression and in the number of apoptotic cells and that
stitial apoptosis. Other investigators have demonstratedNE administration causes neither of these phenomena
suggests a possible role for oxidative stress in the devel- that induction of the HO system has an anti-apoptotic
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Table 4. Effect of hemin and zinc protoporphyrin on angiotensin II-induced tubular and interstitial cell proliferation
Tubular region Interstitial region
Group 1.160.2 1.460.4
Control
Treatment day 3 day 7 day 3 day 7
Ang II 0.7 mg/kg/day 13.162.4b 5.661.8b 16.062.7b 5.560.6b
Hydralazine1Ang II 12.863.4b 4.760.9b 13.262.6b 6.260.8b
Hemin ND 1.060.3c,f ND 1.460.3d,f
Hemin1Ang II 3.460.9b,d,f 4.661.0b 3.260.6b,d,f 4.960.6b,e
ZnPP ND 1.360.4c,f ND 1.360.4d,f
ZnPP1Ang II 19.561.9b,c,e 9.362.0b,c,f 18.662.3b,e 9.360.9b,c,e
Angiotensin II (Ang II) was continuously infused for 7 consecutive days. The number of PCNA-positive cells in each specimen was calculated by counting the
number of PCNA-positive cells in 20 nonoverlapping fields viewed at 3250 magnification. Data from 6 to 8 rats are summarized and expressed as the mean number 6
SEM per high power field. ND indicates not done.
a P , 0.05 and b P , 0.01 compared with the control
c P , 0.05 and d P , 0.01 compared with Ang II (0.7 mg/kg/day)-infused rats
e P , 0.05 and f P , 0.01 compared with hydralazine 1 Ang II group
effect in vitro and in vivo [17, 31]. HO-1 is thought to Ang II-infused rats suggests that oxidative stress may be
involved in the pathogenesis of Ang II-induced apopto-exert its anti-apoptotic effect by regulating cellular iron
sis. Hemin injection decreased the Ang II-induced cell[17] or carbon monoxide [32]. In a previous article, we
proliferation and apoptosis, and ZnPP injection increaseddemonstrated that hemin injection normalized Ang II-
these phenomena in the kidney. Our data suggest thatinduced elevation of blood pressure [16]. Since hydrala-
activation of RAS plays a pivotal role in modulating renalzine treatment significantly, though not completely, sup-
cell proliferation and apoptosis in the setting of hyper-pressed Ang II-induced enhancement of interstitial cell
tension and that the renal HO system may play a roleapoptosis, an anti-apoptotic effect of hemin administra-
in maintaining normal kidney homeostasis in Ang II-tion observed in the present study may be partially ex-
infused rats.plained by its antihypertensive effect. Since hemin (ZnPP)
injection decreased (increased) Ang II-induced enhance-
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